Key Dates

Related Announcements

• October 20, 2023 - NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required). See NOFO PAR-24-051. 

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this Notice is to announce the expiration of PAR-24-051, NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required). No applications are accepted after the May 7, 2025, AIDS due date. The purpose of this Notice is to inform the extramural community that PAR-24-051, NIDCD Low Risk Clinical Trails in Communication Disorders (R01 Clinical Trial Required) will expire June 6, 2025. No further applications will be accepted for consideration under this NOFO.

National Institute on Deafness and Other Communication Disorders encourages applicants to instead consider submitting an application under PA-25-305, “NIH Research Project Grant (Parent R01 Clinical Trial Required)”, or future re-issuances of PA-25-305. 

Inquiries

Please direct all inquiries to:

Samah Jafari, M.D.
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-402-1132
Email: [email protected]